Featured Content The biopharmaceutical and cannabis industries are two sectors undergoing rapid growth and innovation, driven by advancements in medical research and changing consumer demand for both pharmaceuticals and cannabis products. Companies like Context Therapeutics and Organigram are key players in their respective industries, each focusing on cutting-edge technologies and products to meet the needs […]
Read MoreFeatured Content LENZ Therapeutics, Inc. (LENZ) is a biopharmaceutical company that focuses on developing innovative therapies for ophthalmic conditions, particularly for the treatment of presbyopia, an age-related condition that affects near vision. LENZ is committed to improving the quality of life for individuals with vision impairments by bringing cutting-edge treatments to the market. The company’s […]
Read MoreProtagonist Therapeutics, Inc. (PTGX) is a biopharmaceutical company focused on developing peptide-based treatments for various diseases, especially those related to inflammation and autoimmune disorders. The company leverages its proprietary technology platform to create innovative therapies that can be administered orally, which is a significant advantage over traditional injectable treatments. Currently, one of their leading products […]
Read MoreWhen I see stocks trading at or near historical highs I almost always assume that the stock is overvalued. That’s even more true if the stock is near to an all-time high and has been following an upward trend of more than a year. A similar, opposite logic applies to stocks in a downward trend; […]
Read MoreGuardion Health Sciences, Inc. (GHSI) Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific […]
Read More